Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides

Citation
Cj. Wraight et al., Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides, NAT BIOTECH, 18(5), 2000, pp. 521-526
Citations number
47
Categorie Soggetti
Biotecnology & Applied Microbiology",Microbiology
Journal title
NATURE BIOTECHNOLOGY
ISSN journal
10870156 → ACNP
Volume
18
Issue
5
Year of publication
2000
Pages
521 - 526
Database
ISI
SICI code
1087-0156(200005)18:5<521:ROEHIP>2.0.ZU;2-7
Abstract
Epidermal hyperplasia is a key feature of the common skin disorder psoriasi s. Stimulation of epidermal keratinocytes by insulin-like growth factor I ( IGF-I) is essential for cell division, and increased sensitivity to IGF-I m ay occur in psoriasis. We hypothesized that inhibition of IGF-I receptor ex pression in the psoriasis lesion would reverse psoriatic epidermal hyperpla sia by stowing the rate of keratinocyte cell division. Here we report the u se of C5-propynyl-dU,dC-phosphorothioate antisense oligonucleotides to inhi bit IGF-I receptor expression in keratinocytes. We identified several inhib itory antisense oligonucleotides and demonstrated IGF-I receptor inhibition in vitro through an mRNA targeting mechanism. Repeated injection of these oligonucleotides into human psoriasis lesions, grafted onto nude mice, caus ed a dramatic normalization of the hyperplastic epidermis. The findings ind icate that IGF-I receptor stimulation is a rate-limiting step in psoriatic epidermal hyperplasia and that IGF-I receptor targeting by cutaneous admini stration of antisense oligonucleotides forms the basis of a potential new p soriasis therapy.